拔管后经鼻高流量氧疗联合呼吸训练对比传统氧疗对腹部大手术后患者术后肺部并发症的影响:单中心随机对照试验方案
该单中心随机对照试验计划纳入328例腹部大手术患者,拔管后随机分为联合治疗组(经鼻高流量氧疗至少48小时联合每日3次呼吸训练至少72小时)或传统氧疗组(鼻导管或面罩吸氧至少48小时),主要终点为7天内术后肺部并发症发生率,旨在评估联合治疗能否降低该发生率。
要点
- 计划纳入328例腹部大手术患者,拔管后30分钟内启动干预,随机分为联合治疗组与传统氧疗组。
- 联合治疗组接受经鼻高流量氧疗至少48小时及每日3次呼吸训练至少72小时。
- 主要终点为7天内术后肺部并发症发生率,次要终点包括28天死亡率、再插管率、住院时长和1年全因死亡率。
核心结论
- 该试验旨在提供经鼻高流量氧疗联合呼吸训练预防腹部大手术后肺部并发症有效性的证据,以确定改善手术患者预后的最佳治疗方式。
研究设计与样本
- 单中心随机对照试验,计划纳入328例行腹部大手术的患者,拔管后随机分为联合治疗组(A组)或传统氧疗组(B组),干预在拔管后30分钟内开始。
关键数值与推荐
- A组接受经鼻高流量氧疗至少48小时,并每日进行3次呼吸训练至少72小时;B组接受经鼻导管或面罩吸氧至少48小时。
- 主要终点为7天内术后肺部并发症发生率;次要终点包括28天死亡率、再插管率、住院时长和1年全因死亡率。
局限性
- 该试验为单中心研究,且为回顾性注册(注册号ChiCTR2100047146,注册日期2021年6月8日)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nearly 234 million patients undergo surgery each year, and 1.3 million among them develop complications. Patients undergoing major upper abdominal surgery (operation time > 2 h) have a really high incidence of postoperative pulmonary complications (PPCs). The occurrence of PPCs seriously affects the outcomes of patients. High-flow nasal cannula (HFNC) is as effective as noninvasive ventilation (NIV) in preventing postoperative hypoxaemia and respiratory failure. Respiratory training using positive expiratory pressure (PEP) Acapella (Choice) has been shown to help patients with rapid recovery from postoperative atelectasis. However, no relevant randomized controlled studies have been conducted to clarify the effect of HFNC combined with respiratory training in the prevention of PPCs. This study aims to investigate whether the use of HFNC combined with respiratory training could reduce the incidence of PPCs within 7 days after major upper abdominal surgery compared to that with conventional oxygen therapy (COT). METHODS: This is a randomized controlled single-centre trial. A total of 328 patients who undergo major abdominal surgery will be included. Subjects who fulfil the eligible criteria will be randomly assigned into the combination treatment group (Group A) or COT group (Group B) after extubation. The interventions will begin within 30 min of extubation. Patients in Group A will receive HFNC for at least 48 h and respiratory training three times a day for at least 72 h. Patients in Group B will receive oxygen therapy through a nasal catheter or mask for at least 48 h. Our primary endpoint is the incidence of PPCs within 7 days, and the secondary outcome measures include 28-day mortality, reintubation rate, length of hospital stay, and all-cause mortality within 1 year. DISCUSSION: This trial would help provide evidence on the effectivity of applying HFNC combined with respiratory training for the prevention of PPCs in patients undergoing major upper abdominal surgery. The objective of this study is to determine the optimal treatment approach to improve the prognosis of patients undergoing surgery. TRIAL REGISTRATION: ChiCTR2100047146. Registered on 8 June 2021. Retrospectively registered.
引用
- Jin B, Yao M, Shen W, et al. Effect of post-extubation high-flow nasal cannula combined with respiratory training versus conventional oxygen therapy on postoperative pulmonary complications in patients after major abdominal surgery: protocol for a single-centre randomized controlled trial. Trials. 2023. PMID: 37308904. doi:10.1186/s13063-023-07311-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。